Stopping GLP-1 Medications Often Results in Rapid Weight Gain and MORE…
by Dr. Richard Lipman MD
Board Certified in Internal Medicine/Endocrinology
Stopping GLP-1 treatment does not simply “remove a diet drug.” It removes a medication that was suppressing hunger, food noise, cravings, gastric emptying, and reward-driven eating. At the same time, the body has already adapted to the lower weight by reducing energy expenditure(metabolism) and increasing biological pressure to regain weight. What happens to your weight at that time?
Tirzepatide and Semaglutide: Individuals Quickly Regain the Weight When Stopping Treatment
In the STEP 1 semaglutide extension, patients regained about two-thirds of the weight they had lost within 1 year after stopping semaglutide, and cardiometabolic improvements moved back toward baseline. In SURMOUNT-4, patients who continued tirzepatide maintained far more weight loss than those who switched to placebo, supporting the idea that obesity usually needs ongoing treatment.
Main Consequences of Stopping GLP-1’s When You Reach Your Goal:
1. Hunger returns before major weight gain appears; this is often due to increased ghrelin.
The first sign is usually not weight gain. It is the return of:
- Food noise: very subtle at first. Since you are trying to limit food, the first thought is that it’s not food noise but actually hunger.
- Bigger portions
- Night eating
- Cravings for sweets or starches
- Alcohol interest
- Less control once eating starts
- This is important because by the time the scale rises 8–10 lb, the behavioral pattern has usually been back for weeks.
Table 1 below reveals the time sequence of the changes in hunger, food noises, and mood changes that come with stopping the GLP-` medications over twelve months
Table 1:
2. The body now burns fewer calories:
After major weight loss, the patient has a smaller body and therefore needs fewer calories. In addition, weight loss can produce adaptive thermogenesis, meaning the body may burn fewer calories than predicted for the new weight. Then the trap:
So a patient may think: “I’m eating less than before.”…….But the body’s new maintenance calorie level may be much lower.
3. Muscle loss can worsen the risk of regaining weight because of a fall in metabolism.
During rapid GLP-1 weight loss, patients lose both fat and lean muscle mass. If they do not maintain protein and resistance exercise, they may reach their goal weight with:
- Less muscle
- Lower resting metabolic rate
- More fatigue
- Less strength
- Higher chance of fat regain
When weight returns, it may come back disproportionately as fat rather than muscle. With less muscle, metabolism falls.
4. Cardio-metabolic benefits may reverse:
The benefits of GLP-1 weight loss often include improvement in:
- Blood sugar
- Insulin resistance
- Blood pressure
- Triglycerides
- Waist circumference
- Fatty liver markers
- Sleep apnea symptoms
After stopping and regaining weight, many of these improvements can drift back toward baseline. The semaglutide STEP 1 extension specifically found that cardiometabolic improvements tended to revert toward baseline after withdrawal.
5. Mood and self-blame can worsen:
Patients often feel they “failed,” but the physiology is predictable. GLP-1s reduce hunger and reward-driven eating. When the medication is removed, the original biology often returns.
A better message:
Weight regain after stopping GLP-1 is usually not a willpower failure. It is a biologic relapse of a chronic weight-regulation problem.
What You Need to Watch for if You Stop GLP-1’s
A patient who has stopped at goal should be monitored closely if they develop any of the following symptoms, as shown in Table 2.
Table 2
